Company Search:
Advanced Search
Sponsored Links
Mirati Therapeutics Inc Company Snapshot
Mirati Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Mirati Therapeutics Inc with three other companies in this sector in Canada: Ceapro Inc (2018 sales of 11.59 million Canadian Dollars [US$8.88 million] of which 100% was Active Ingredient Product Technology Ind), Microbix Biosystems Inc (12.51 million Canadian Dollars [US$9.59 million] ), and Opiant Pharmaceuticals Inc (18.17 million Canadian Dollars [US$13.92 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Mirati Therapeutics Inc
  Stock Performance Chart for Mirati Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/12/2019): 137.95
(Figures in Canadian Dollars)
1 Week -1.5%   13 Weeks 9.1%  
4 Weeks 56.8%   52 Weeks 112.8%  
Mirati Therapeutics Inc Key Data:
  Ticker: MRTX Country: United States
  Exchanges: TOR Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 16,797,078
(Year Ending Jan 2019).
Employees: 63
  Currency: Canadian Dollars Market Cap: 4,972,757,043
  Fiscal Yr Ends: December Shares Outstanding: 36,047,127
  Share Type: COMMON Closely Held Shares: 550,929
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.